Dapsone
$ 80,00 – $ 180,00Price range: $ 80,00 through $ 180,00
DDAVP spray
$ 64,00 – $ 412,00Price range: $ 64,00 through $ 412,00
Daxid
$ 42,00 – $ 229,00Price range: $ 42,00 through $ 229,00
Daxid is a highly effective medication belonging to the class of selective serotonin reuptake inhibitors (SSRIs). It is primarily utilized to manage major depressive disorder by helping to restore the balance of natural chemicals in the brain. This treatment is also widely indicated for individuals struggling with obsessive-compulsive disorder and panic attacks. Furthermore, Daxid provides significant relief for patients experiencing social anxiety disorder and post-traumatic stress disorder. By improving mood, sleep, and energy levels, this medication helps patients regain control over their daily lives and emotional well-being.
Active substance: Sertraline
SKU:
Daxid
Category: AntiDepressants
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM
Each dosage option has its own packaging choices.
Description
Daxid belongs to a class of medications known as selective serotonin reuptake inhibitors (SSRIs). It is a prescription-only pharmaceutical agent indicated for the management of major depressive disorder, obsessive-compulsive disorder, panic disorder, posttraumatic stress disorder, social anxiety disorder, and premenstrual dysphoric disorder in adult and eligible pediatric patients.
Treatment with Daxid must be conducted under the direct supervision of a qualified healthcare provider in accordance with federal and state prescription regulations. Safe administration requires precise adherence to prescribed dosage regimens and awareness of potential drug interactions, contraindications, and side effect profiles.
| Parameter | Specification |
|---|---|
| Drug name | Daxid |
| Active ingredient | Sertraline hydrochloride |
| Therapeutic class | Selective Serotonin Reuptake Inhibitor (SSRI) |
| Dosage form | Oral tablet |
| Route of administration | Oral |
| Prescription status | Prescription (Rx) only |
Clinical Profile and Pharmacological Properties
How the drug works
Daxid exerts its primary pharmacological action through the potent and selective inhibition of neuronal reuptake of serotonin (5-hydroxytryptamine, or 5-HT) within the central nervous system. By binding to the presynaptic serotonin transporter protein, the medication inhibits the reuptake of serotonin into the presynaptic terminal, thereby enhancing serotonergic neurotransmission and increasing the concentration of active 5-HT within the synaptic cleft. Daxid exhibits minimal affinity for norepinephrine and dopamine transporters under standard therapeutic dosing conditions. Furthermore, it displays negligible binding affinity for muscarinic cholinergic, histaminergic, alpha-1 adrenergic, and beta-adrenergic receptors, which contributes to its distinct tolerability profile relative to tricyclic antidepressants.
What happens in the body
Following oral administration of Daxid, sertraline is slowly absorbed from the gastrointestinal tract, reaching peak plasma concentration ($C_{max}$) between 4.5 and 8.4 hours post-dose. Peak concentrations and total area under the plasma concentration-time curve are proportional to the administered dose within the standard clinical dosing range. Sertraline undergoes extensive hepatic first-pass metabolism, primarily via N-demethylation to form N-desmethylsertraline, a metabolite with significantly reduced pharmacological activity compared to the parent compound. Plasma protein binding of sertraline is high, measuring approximately 98%. The average elimination half-life of sertraline is approximately 26 hours. Excretion occurs in roughly equal proportions through the biliary-fecal route and renal elimination.
Main uses
Daxid is indicated for the treatment of major depressive disorder in adults. It is also FDA-approved for the management of obsessive-compulsive disorder in adult and pediatric patients aged 6 years and older. Additional approved indications in adult populations include panic disorder (with or without agoraphobia), posttraumatic stress disorder, social anxiety disorder, and premenstrual dysphoric disorder. Any clinical application outside of these specific approved diagnostic categories represents off-label use and must be evaluated on an individual basis by a licensed prescribing practitioner.
Dosing schedule
Daxid tablets are administered orally once daily, either in the morning or evening, with or without food. For major depressive disorder and obsessive-compulsive disorder, the recommended initial dose is 50 mg daily. For panic disorder, posttraumatic stress disorder, and social anxiety disorder, therapy is typically initiated at 25 mg daily for one week before increasing to 50 mg daily. Depending on clinical response and tolerability, dose adjustments may occur at intervals of no less than one week, up to a maximum dosage of 200 mg daily. Patients treated for premenstrual dysphoric disorder may follow continuous daily dosing or luteal-phase daily dosing as determined by the prescriber.
Safety Information, Interactions, and Common Questions
Adverse reactions
Clinical data indicate that Daxid is associated with specific side effect profiles. The most frequently observed adverse events involve the gastrointestinal system, including nausea, diarrhea, loose stools, dyspepsia, abdominal pain, and dry mouth. Central nervous system adverse effects include somnolence, insomnia, dizziness, tremor, anxiety, and fatigue. Increased sweating (hyperhidrosis) and decreased appetite are also documented. Sexual dysfunction–manifesting as delayed ejaculation, erectile dysfunction, decreased libido, or anorgasmia–may occur during treatment and can persist in some individuals. Modest weight changes, including initial loss or subsequent gain, have been observed during long-term clinical monitoring.
What not to combine
Concomitant administration of Daxid with monoamine oxidase inhibitors (MAOIs) is strictly contraindicated due to the severe risk of fatal serotonin syndrome. A minimum wash-out period of 14 days must elapse between discontinuing an MAOI and initiating Daxid, and vice versa. Co-administration with pimozide is prohibited due to the risk of QT interval prolongation and cardiac dysrhythmias. The concurrent use of Daxid with other serotonergic agents–including triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, linezolid, intravenous methylene blue, and St. John’s wort–increases the likelihood of serotonin toxicity. Combining Daxid with nonsteroidal anti-inflammatory drugs (NSAIDs), aspirin, or oral anticoagulants like warfarin increases the risk of upper gastrointestinal bleeding events.
Important precautions
Antidepressants, including Daxid, carry a boxed warning regarding an increased risk of suicidal thoughts and behaviors in children, adolescents, and young adults up to 24 years of age during initial treatment phases. Prescribers and caregivers must monitor patients closely for clinical worsening, agitation, or emergent suicidal ideation. Daxid should be prescribed with caution in patients with a pre-existing history of seizure disorders, bipolar disorder, or hepatic impairment. In patients with severe hepatic impairment, lower doses or less frequent administration schedules are recommended. Use during pregnancy requires careful clinical risk-benefit assessment; exposure during the third trimester may increase the risk of persistent pulmonary hypertension of the newborn (PPHN) or neonatal adaptation syndrome. Sertraline is excreted into human breast milk in small amounts; infant exposure should be evaluated individually.
What to avoid while taking it
Food does not significantly alter the overall bioavailability of Daxid tablets, although taking the medication with meals can slightly increase peak plasma concentrations. Patients are advised to refrain from alcohol consumption while undergoing Daxid therapy. Alcohol co-ingestion can potentiate central nervous system depression, compounding sedation, motor impairment, and cognitive slowing. Furthermore, patients should avoid unauthorized initiation of dietary supplements containing L-tryptophan or high doses of 5-HTP due to additive serotonergic effects.
Red flags
Immediate emergency medical care is required if a patient demonstrates signs of serotonin syndrome, such as high fever, severe agitation, confusion, muscle rigidity, hyperreflexia, rapid heartbeat, or extreme shivering. Emergency medical attention is also required if symptoms of a severe hypersensitivity reaction emerge, including angioedema of the face, lips, tongue, or throat, or acute dyspnea. Other critical indicators requiring urgent medical evaluation include sudden skin eruption with blistering, severe or worsening suicidal ideation, new-onset seizures, acute visual disturbances with ocular pain (indicative of angle-closure glaucoma), or unusual, heavy bleeding.
If you skip a dose
If a dose of Daxid is omitted, the missed tablet should be taken as soon as it is remembered on the same day. However, if it is nearly time for the next scheduled dose, the missed dose should be skipped entirely, and the established dosing schedule resumed. Patients must not double the dose to make up for a forgotten tablet. Consistency in daily administration timing aids in maintaining stable systemic concentrations.
Practical tips
To support consistent systemic levels, Daxid should be taken at approximately the same time every day. Patients experiencing daytime drowsiness may benefit from evening dosing following consultation with their healthcare provider, whereas patients experiencing insomnia may prefer morning administration. Abrupt discontinuation of Daxid must be avoided, as rapid withdrawal can precipitate antidepressant discontinuation syndrome, characterized by dizziness, sensory disturbances, electric shock sensations, anxiety, headache, and nausea. Tapering of the dose must always be performed under direct medical guidance.
Common questions
How long does it typically take to notice therapeutic improvements after starting Daxid?
Initial symptomatic changes, such as improvements in sleep patterns, energy, or appetite, may occur within 1 to 2 weeks of starting therapy. However, full therapeutic efficacy for depressive and anxiety symptoms typically requires 4 to 6 weeks of continuous daily administration at an adequate clinical dose.
Can Daxid cause weight changes during long-term treatment?
Weight changes vary significantly among patients taking Daxid. Initial therapy may cause mild appetite suppression and transient weight reduction, whereas prolonged treatment can be associated with modest weight gain in some individuals. Routine monitoring of weight and metabolic parameters by a clinician is recommended.
Is it safe to drive or operate machinery while taking Daxid?
Daxid may induce somnolence, dizziness, or impaired cognitive reflexes in certain individuals. Patients should evaluate their personal functional response to the medication prior to driving, operating heavy machinery, or performing tasks requiring full alertness.
What steps should be taken if Daxid treatment needs to be discontinued?
Daxid treatment should never be stopped abruptly. Prescribers implement a gradual dosage reduction scheme (tapering) over several weeks to minimize the emergence of withdrawal symptoms such as paresthesias, dizziness, agitation, and flu-like symptoms.
Does Daxid interact with over-the-counter pain relievers?
Yes, Daxid interacts with nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen, naproxen, and aspirin. Concomitant use impairs platelet aggregation and increases the risk of upper gastrointestinal tract bleeding, necessitating clinical oversight or alternative pain management strategies.
In accordance with FDA prescription safety guidelines.
This text is for informational purposes only and does not constitute individual medical advice.
Additional information
| Dosage |
100 mg |
|---|---|
| Package |
30 pills ,60 pills ,90 pills ,120 pills ,180 pills ,270 pills ,360 pills |
| Ενεργός Ουσία |
Related products
Amitriptyline
$ 41,00 – $ 114,00Price range: $ 41,00 through $ 114,00
Active substance: amitriptyline
More Details
This product has multiple variants. The options may be chosen on the product page
Anafranil
$ 41,00 – $ 457,00Price range: $ 41,00 through $ 457,00
Active substance: Clomipramine
More Details
This product has multiple variants. The options may be chosen on the product page
Asendin
$ 41,00 – $ 369,00Price range: $ 41,00 through $ 369,00
Active substance: Amoxapine
More Details
This product has multiple variants. The options may be chosen on the product page
Bupron SR
$ 50,00 – $ 510,00Price range: $ 50,00 through $ 510,00
Active substance: Bupropion
More Details
This product has multiple variants. The options may be chosen on the product page
Bupropion
$ 41,00 – $ 297,00Price range: $ 41,00 through $ 297,00
Active substance: Bupropion
More Details
This product has multiple variants. The options may be chosen on the product page
Clofranil
$ 47,00 – $ 318,00Price range: $ 47,00 through $ 318,00
Active substance: Clomipramine
More Details
This product has multiple variants. The options may be chosen on the product page
Duzela
$ 36,00 – $ 83,00Price range: $ 36,00 through $ 83,00
Active substance: Duloxetine
More Details
This product has multiple variants. The options may be chosen on the product page
Pexep
$ 42,00 – $ 162,00Price range: $ 42,00 through $ 162,00
Active substance: paroxetine
More Details
This product has multiple variants. The options may be chosen on the product page
